Education
About Us
Working with TipRanks
Follow Us
Scilex Holding Co Insider Profile
4 Followers
Scilex Holding Co, Ten Percent Owner at Semnur Pharmaceuticals, holds 265.10M shares in Datavault AI (Ticker: DVLT), holds 188.55M shares in Semnur Pharmaceuticals (Ticker: SMNR). Most recently, Scilex Holding Co Sold ― shares of Datavault AI on Nov 28, 2025 for an estimated value of $869.94K.
Scilex Holding Co has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Scilex Holding Co holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Scilex Holding Co
Scilex Holding Co's Trading History
Semnur Pharmaceuticals
Sep 25, 2025
Ten Percent Owner
Informative Sell
200.00M
$1.70B
Datavault AI
Nov 28, 2025
Ten Percent Owner
Informative Sell
869.94K
$538.16M
List of latest transactions for each holding click on a transaction to see Scilex Holding Co's performance on stock
You May Also Like
Scilex Holding Co insider profile FAQ
What is the percentage of profitable transactions made by Scilex Holding Co?
The percentage of profitable transactions made by Scilex Holding Co is ―.
What is the average return per transaction made by Scilex Holding Co?
The average return per transaction made by Scilex Holding Co is ―.
What stocks does Scilex Holding Co hold?
Scilex Holding Co holds: SMNR, DVLT stocks.
What was Scilex Holding Co’s latest transaction?
Scilex Holding Co latest transaction was an Informative Sell of $869.94K.
What was Scilex Holding Co's most profitable transaction?
Scilex Holding Co’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Scilex Holding Co's role in Semnur Pharmaceuticals?
Scilex Holding Co's role in Semnur Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.